Assessment of smoking in patients with severe chronic respiratory failure treated with oxygen for long periods at home;Evaluation du tabagisme chez les insuffisants respiratoires chroniques graves traites par oxygene de longue duree a domicile

Revue des Maladies Respiratoires

Volumn 13, Issue 4, 1996, Pages 405-411

  Cornette, A ^a   Petitdemange, I ^a   Briancon, S ^a   Burlet, C ^a   Polu, J M ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

active and passive smoking; oxygenotherapy; respiratory insufficiency; urinary cotinine

Indexed keywords

NICOTINE;

ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PASSIVE SMOKING; QUESTIONNAIRE; RESPIRATORY FAILURE; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; COTININE; FEMALE; FRANCE; HOME CARE SERVICES; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RESPIRATORY INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 0029780793     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. LEVI-VALENSI P: Indications, conditions de prescription et surveillance d'un appareil d'assistance respiratoire. Bull Physiopath Resp 1986;22(Suppl 9):79-125.
2. DOLL R, PETO R, WHEATLEY K, GRAY R, SUTHERLAND I: Mortality in relation to smoking : 40 years'observations on male British doctors. BMJ 1994;309:901-10.
3. TREDANIEL J, HILL C, CHASTANG CI, HIRSCH A: Tabagisme passif et maladies respiratoires. Données actuelles. Rev Mal Respir 1989;6:109-20.
4. FREJAVILLE JP, BOURDON P: Oxyde de carbone. In: Toxicologie clinique et analytique. Paris: Flammarion, 1976:524-9.
5. PEREZ-STABLE EJ, MARIN G, MARIN BV, BENOWITZ NL: Misclassification of smoking status by self-reported cigarette consumption. Am Rev Respir Dis 1992;145:53-7.
6. POLU JM: Surveillance à domicile et observance du traitement des insuffisants respiratoires chroniques graves. Bull Eur Physiopath Resp 1986;22(Suppl 9):86-9s.
7. ROZIÈRES S, ROYER S: Rôle de l'infirmière d'Association dans le traitement à domicile des insuffisants respiratoires graves. Bull Eur Physiopath Resp 1986;22(Suppl 9):48-55s.
8. VAN VUNAKIS H, GJIKA HB, LANCONE JJ: Method 16 RIA for nicotine and cotinine in environmental carcinogens methods and analysis and exposure measurements. IARC Scient Public 1987;81:317-30.
9. HOFFMANN D, BRUNNEMANN KD: Endogenous formation of N-nitrosoproline in cigarette smokers. Cancer Res 1983;43:5570-4.
10. HORSTMANN M: Simple high-performance liquid chromatographic method for rapid determination of nicotine and cotinine in urine. J Chromatogr 1985;344:391-6.
11. WALD NJ, BOREHAM J, BAILEY A, RITCHIE C, HADDOW JE, KNIGHT G: Urinary cotinine as marker of breathing other people's tobacco smoke. Lancet 1984;1:230-1.
12. THOMPSON SG, STONE R, NANCHAHAL K, WALD NJ: Relation of urinary cotinine concentrations to cigarette smoking and to exposure to other people's smoke. Thorax 1990;45:356-61.
13. GREENBERG RA, HALEY NJ, ETZEL RA, LODA FA: Measuring the exposure of infants to tobacco smoke. N Engl J Med 1984;310:1075-8.
14. ADLKOFER F, SCHERER G, HEES UV: Passive smoking. N Engl J Med 1985;312:719-20.
15. DIXON DJ: BMDP statistical software. University of California Press 1990.
16. JARVIS MJ, TUNSTALL-PEDOE H, FEYERABEND C, VESEY C, SALOOJEE Y: Comparison of tests used to distinguish smokers from non smokers. Am J Public Health 1987;77:1435-8.
17. BENOWITZ NL: Clinical pharmacology of nicotine. Ann Rev Med 1986;37;21-32.
18. PRIGNOT J: Quantification and chemical markers of tobacco exposure. Eur J Respir Dis 1987;70:1-7.
19. MATSUYAMA H, MURANAKA H: Effects of pH and urine flow on urinary nicotine excretion after smoking cigarettes. Clin Pharmacol Ther 1979;25:549-54.
20. HENNEKENS Ch, BURING JE: Smoking and coronary heart disease in women. JAMA 1985;253:3003-4.
21. SPENGLER JD, SEXTON K: Indoor air pollution: a public health perspective. Science 1983;221:9-17.
22. RUSSEL MAH, COLE PV, BROWN E: Absorption by non-smokers of carbon monoxide from room air polluted by tobacco smoke. Lancet 1973;1:576-9.
23. BENOWITZ NL: The use of biologic fluid samples in assessing tobacco smoke consumption. In: Grabowski J, Bell CS, eds. Measurement in the analysis and treatment of smoking behavior. National Institute on Drug Abuse. Research Monograph 48. Rockville, MD: Department of Health and Human Services, 1983. DHHS Publication No. (ADM) 83-1285.
24. ROUSSEL G, LE QUANG NT, MIGUÈRES ML, ROCHE D, CHRÉTIEN J, EKINDJIAN OG: Interprétation des valeurs de la cotininurie chez les fumeurs et les non-fumeurs. Rev Mal Respir 1991;8:225-32.
25. LANGONE JJ, GJIKA HB, VAN VUNAKIS H: Nicotine and 119 metabolites: radio-immuno assays for nicotine and cotinine. Biochemistry 1973;12:5025-30.
26. JOHNSON LC, LETZEL H, KLEINSCHMIDT J: Passive smoking under controlled conditions. Int Arch Occup Environ Health 1985;56:99-110.
27. LETZEL H, FISCHER-BRANDIES A, JOHNSON LC, UBERLA K, BIBER A: Measuring problems in estimating the exposure to passive smoking using the excretion of cotinine. Toxicol Lett 1987;35:35-44.
28. WALL MA, JOHNSON J, JACOB P, BENOWITZ NL: Cotinine in the serum, saliva and urine of non smokers, passive smokers and active smokers. Am J Public Health 1988;78: 699-701.
29. HOFFMANN D, HALEY NJ, ADAMS JD, BRUNNEMANN KD: Tobacco sidestream smoke: uptable by nonsmokers. Prev Med 1984;13:608-17.
30. HENDERSON FW, REID HF, MORRIS R, WANG OL, HU PC, HELMS RW, FOREHAND L, MUMFORD J, LEWTAS J, HALEY NJ, HAMMOND SK: Home air nicotine levels and urinary cotinine excretion in preschool children. Am Rev Respir Dis 1989;140:197-201.
31. MATSUKURA S, TAMINATO T, KITANO N, SEINO Y, HAMADA H, UCHIHASHI M, NAKAJIMA H, HIRATA Y: Effects of environmental tobacco smoke on urinary cotinine excretion in non smokers. N Engl J Med 1984;311:828-32.
32. WALD NJ, NANCHAHAL K, THOMPSON SG, CUCKLE HS: Does breathing other people's tobacco smoke cause lung cancer? Br Med J 1986;293:1217-22.
33. CUMMINGS KM, MARKELLO SJ, MAHONEY M, BHARGAVA AK, MCELROY PD, MARSCHALL JR: Measurement of current exposure to environmental tobacco smoke. Arch Environ Health 1990;45:74-9.
34. JARVIS N, TUNSTALL-PEDOE H, FEYERABEND C, VESEY C, SALLOOJEE Y: Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health 1984;38:335-9.
35. WILCOX RG, HUGUES J, ROLAND J: Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br Med J 1979;2:1026-8.
36. KORWIN JD (DE), ROYER-MORROT MJ, PAYAN E, SCHMITT J, ROYER RJ: Contrôle de l'observance des consignes d'arrêt du tabac chez des malades artéritiques. Intérêt des dosages urinaires de nicotine et cotinine. Ann Med de Nancy et de l'Est 1990;29:189-94.
37. COHEN JD, BARTSCH GE: A comparison between carboxyhemoglobin and serum thiocyanate determinations as indicators of cigarette smoking. Am J Public Health 1980;70:284-6.
38. SVENSSON GK: Clinical pharmacokinetics of nicotine. Clin Pharmacokinetics 1987;12:30-40.
39. PIERCE JP, DWYER T, DIGIUSTO E et al.: Cotinine validation of self-reported smoking in commercially run community surveys. J Chron Dis 1987;40:689-95.
40. TREDANIEL J, KARSENTY S, CHASTANO CI, SLAMA K, HIRSCH A: Les habitudes tabagiques des médecins généralistes français. Rev Mal Respir 1993;10:35-8.
41. NOTT (NOCTURNAL OXYGEN THERAPY TRIAL GROUP): Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980;93: 391-8.
42. MRC (MEDICAL RESEARCH COUNCIL WORKING PARTY).: Report of long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complications chronic bronchitis and emphysema. Lancet 1981;1:681-5.